Ahn D S, Lee Y H, Kang D H, Kang B S
Yonsei University College of Medicine, Department of Physiology, Seoul, Korea.
Yonsei Med J. 1994 Jun;35(2):162-76. doi: 10.3349/ymj.1994.35.2.162.
Cytosolic Ca2+ concentration of rat ventricular cells was measured under varying experimental conditions by using a fluorescent Ca2+ indicator, Fura-2. Resting [Ca2+]i of rat myocyte was 150 +/- 30 nM (n = 39), and this value was compatible with others. The Perfusion of cardioplegic solution significantly increased [Ca2+]i, and this effect was further augmented by hypothermia (p < 0.05). Application of nifedipine (5 x 10(-7) M) to the perfusate or pretreatment of caffeine (10 mM) had no apparent effect on this cardioplegia-induced [Ca2+]i change. But Ni2+ (5 mM), an antagonist of Na+/Ca2+ exchange mechanism, prevented the [Ca2+]i change during cardioplegia (p < 0.05). Magnitude of cardioplegia-induced [Ca2+]i increase was also dependent on the Ca2+ concentration of cardioplegic solution. These results suggest that Na+/Ca2+ exchange may play an important role in cardioplegia-induced [Ca2+]i change. To rule out the possibility whether the protective effect of hypothermic cardioplegia is due to the preservation of high-energy phosphate store or decreasing the transmembrane ionic fluxes by phase transition, we exhausted a energy store of cardiac cell by application of 2,4 dinitrophenol to the bath and measured its effect on [Ca2+]i change during cardioplegia. Hypothermic cardioplegia delayed the onset of [Ca2+]i increase and decreased its amplitude compared to those of normothermic cardioplegia. From the above results, hypothermic cardioplegia may protect the cardiac cells from ischemic insult by preserving a high-energy phosphate store. Application of Ni2+ to the cardioplegic solution or reduction of external Ca2+ concentration also had some protective effect, since it prevented [Ca2+]i increase during cardioplegia.
采用荧光钙指示剂Fura-2,在不同实验条件下测定大鼠心室细胞的胞质钙浓度。大鼠心肌细胞的静息[Ca2+]i为150±30 nM(n = 39),该值与其他研究结果相符。灌注心脏停搏液显著增加了[Ca2+]i,低温可进一步增强这种作用(p < 0.05)。向灌注液中加入硝苯地平(5×10(-7) M)或预先给予咖啡因(10 mM)对心脏停搏引起的[Ca2+]i变化无明显影响。但Na+/Ca2+交换机制的拮抗剂Ni2+(5 mM)可阻止心脏停搏期间的[Ca2+]i变化(p < 0.05)。心脏停搏引起的[Ca2+]i增加幅度也取决于心脏停搏液的钙浓度。这些结果表明,Na+/Ca2+交换可能在心脏停搏引起的[Ca2+]i变化中起重要作用。为排除低温心脏停搏的保护作用是否归因于高能磷酸储存的保存或通过相变减少跨膜离子通量的可能性,我们通过向浴槽中加入2,4-二硝基苯酚耗尽心肌细胞的能量储存,并测量其对心脏停搏期间[Ca2+]i变化的影响。与常温心脏停搏相比,低温心脏停搏延迟了[Ca2+]i增加的起始时间并降低了其幅度。根据上述结果,低温心脏停搏可能通过保存高能磷酸储存来保护心肌细胞免受缺血损伤。向心脏停搏液中加入Ni2+或降低细胞外钙浓度也有一定的保护作用,因为它可阻止心脏停搏期间的[Ca2+]i增加。